# Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?

> **NCT03011268** · NA · COMPLETED · sponsor: **Helse Møre og Romsdal HF** · enrollment: 174 (actual)

## Conditions studied

- Colitis,Ulcerative

## Interventions

- **OTHER:** Discontinuation of anti-TNF treatment
- **OTHER:** Continuation of anti-TNF treatment

## Key facts

- **NCT ID:** NCT03011268
- **Lead sponsor:** Helse Møre og Romsdal HF
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-09
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011268, "Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03011268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*